Xu Y - Search Results

1

Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screening.

Zou F, Pusch S, Hua J, Ma T, Yang L, Zhu Q, Xu Y, Gu Y, von Deimling A, Zha X. Zou F, et al. Among authors: xu y. Bioorg Med Chem Lett. 2018 Feb 1;28(3):388-393. doi: 10.1016/j.bmcl.2017.12.030. Epub 2017 Dec 13. Bioorg Med Chem Lett. 2018. PMID: 29290542

2

Benzimidazol-2-yl or benzimidazol-2-ylthiomethyl benzoylguanidines as novel Na+/H+ exchanger inhibitors, synthesis and protection against ischemic-reperfusion injury.

Zhang R, Lei L, Xu YG, Hua WY, Gong GQ. Zhang R, et al. Bioorg Med Chem Lett. 2007 May 1;17(9):2430-3. doi: 10.1016/j.bmcl.2007.02.035. Epub 2007 Feb 17. Bioorg Med Chem Lett. 2007. PMID: 17346962

3

Design, synthesis and biological evaluation of novel substituted benzoylguanidine derivatives as potent Na+/H+ exchanger inhibitors.

Xu WT, Jin N, Xu J, Xu YG, Wang QJ, You QD. Xu WT, et al. Bioorg Med Chem Lett. 2009 Jun 15;19(12):3283-7. doi: 10.1016/j.bmcl.2009.04.079. Epub 2009 Apr 23. Bioorg Med Chem Lett. 2009. PMID: 19433354

4

Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivatives.

Zhang R, Dong J, Xu YG, Hua WY, Wen N, You QD. Zhang R, et al. Eur J Med Chem. 2009 Sep;44(9):3771-6. doi: 10.1016/j.ejmech.2009.04.036. Epub 2009 May 5. Eur J Med Chem. 2009. PMID: 19482383

5

Synthesis and Na+/H+ exchanger inhibitory activity of benzoylguanidine derivatives.

Jin L, Jiang XM, Du P, Xu J, Gong GQ, Wang QJ, Xu YG. Jin L, et al. Eur J Med Chem. 2011 Sep;46(9):4107-16. doi: 10.1016/j.ejmech.2011.06.011. Epub 2011 Jun 17. Eur J Med Chem. 2011. PMID: 21724305

6

Design, synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing methyl ferulate.

Yang XZ, Diao XJ, Yang WH, Li F, He GW, Gong GQ, Xu YG. Yang XZ, et al. Bioorg Med Chem Lett. 2013 Apr 1;23(7):2089-92. doi: 10.1016/j.bmcl.2013.01.126. Epub 2013 Feb 8. Bioorg Med Chem Lett. 2013. PMID: 23466230

7

Design, synthesis and biological evaluation of novel imidazo[4,5-c]pyridinecarboxamide derivatives as PARP-1 inhibitors.

Zhu Q, Wang X, Chu Z, He G, Dong G, Xu Y. Zhu Q, et al. Among authors: xu y. Bioorg Med Chem Lett. 2013 Apr 1;23(7):1993-6. doi: 10.1016/j.bmcl.2013.02.032. Epub 2013 Feb 16. Bioorg Med Chem Lett. 2013. PMID: 23481647

8

Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor.

Zhang X, Peng T, Ji X, Li J, Tong L, Li Z, Yang W, Xu Y, Li M, Ding J, Jiang H, Xie H, Liu H. Zhang X, et al. Among authors: xu y. Bioorg Med Chem. 2013 Dec 15;21(24):7988-98. doi: 10.1016/j.bmc.2013.09.049. Epub 2013 Oct 2. Bioorg Med Chem. 2013. PMID: 24183742

9

Synthesis and pharmacological evaluation of novel limonin derivatives as anti-inflammatory and analgesic agents with high water solubility.

Yang Y, Wang X, Zhu Q, Gong G, Luo D, Jiang A, Yang L, Xu Y. Yang Y, et al. Among authors: xu y. Bioorg Med Chem Lett. 2014 Apr 1;24(7):1851-5. doi: 10.1016/j.bmcl.2014.02.003. Epub 2014 Feb 10. Bioorg Med Chem Lett. 2014. PMID: 24569111

10

Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.

Shi L, Wu TT, Wang Z, Xue JY, Xu YG. Shi L, et al. Eur J Med Chem. 2014 Sep 12;84:698-707. doi: 10.1016/j.ejmech.2014.07.071. Epub 2014 Jul 21. Eur J Med Chem. 2014. PMID: 25064347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,109 results

Search Page

Filters